We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 2,244 results
  1. Mesenchymal Stem Cell–Based Therapy as a New Approach for the Treatment of Systemic Sclerosis

    Systemic sclerosis (SSc) is an intractable autoimmune disease with unmet medical needs. Conventional immunosuppressive therapies have modest efficacy...

    **ufen Zhuang, **ao Hu, ... Yanhong Wu in Clinical Reviews in Allergy & Immunology
    Article 15 January 2022
  2. Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis

    Background

    Idiopathic pulmonary fibrosis (IPF) is a progressive form of fibrosing interstitial pneumonia with poor survival. This study provides...

    Michael Kreuter, Nils Picker, ... Haridarshan Patel in Respiratory Research
    Article Open access 19 March 2022
  3. Treatment of heart failure with preserved ejection fraction with SGLT2 inhibitors: new therapy standard?

    Heart failure with preserved ejection fraction (HFpEF) is a common and difficult-to-treat heart disease. Approximately half of patients with heart...

    Christian A. Schneider, Roman Pfister in Herz
    Article 26 August 2022
  4. Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival

    Background

    Idiopathic pulmonary fibrosis (IPF) is associated with increased expression of cyclin-dependent kinase inhibitors such as p16 and p21, and...

    Jonathan Keow, Matthew J. Cecchini, ... Marco Mura in Respiratory Research
    Article Open access 07 June 2022
  5. The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases

    Usual Interstitial Pneumonia (UIP) is characterized by progression of lung parenchyma that may be observed in various autoimmune rheumatic diseases...

    Fabrizio Luppi, Andreina Manfredi, ... Marco Sebastiani in BMC Pulmonary Medicine
    Article Open access 11 December 2023
  6. Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease

    Progressive fibrosing interstitial lung disease (PF-ILD) has been redefined as a new clinical syndrome that shares similar genetics, pathophysiology,...

    Charlisa D. Gibson, Matthias C. Kugler, ... Rany Condos in Lung
    Article 26 June 2020
  7. Lung function trajectories in patients with idiopathic pulmonary fibrosis

    Background

    Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease characterised by decline in lung function. We...

    Megan L Neely, Anne S Hellkamp, ... Scott M Palmer in Respiratory Research
    Article Open access 24 August 2023
  8. High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy

    Background

    Progressive hepatic fibrosis leads to hepatocellular carcinoma (HCC) and decompensated cirrhosis. The aim of this study was to identify the...

    Article 16 March 2023
  9. The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study

    Purpose

    Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease found mostly in elderly persons, characterized by a high symptom...

    Ingrid A. Cox, Barbara de Graaff, ... Andrew J. Palmer in The European Journal of Health Economics
    Article Open access 27 October 2022
  10. Does an Aspirin a Day Take the MASLD Away?

    Although aspirin is deeply rooted in the most ancient history of medicine, the mechanism of action of this drug was only identified a few decades...

    Amedeo Lonardo, Ming-Hua Zheng in Advances in Therapy
    Article 15 May 2024
  11. Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis

    Introduction

    Prevalence of cardiac and vascular fibrosis in patients with Idiopathic Pulmonary Fibrosis (IPF) has not been extensively evaluated.

    ...
    Paola Faverio, Alessandro Maloberti, ... Cristina Giannattasio in High Blood Pressure & Cardiovascular Prevention
    Article Open access 13 May 2024
  12. Association between weight loss and mortality in idiopathic pulmonary fibrosis

    Rationale

    Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease that has no cure. Many current research efforts...

    Aleksandr Kalininskiy, Ashley Rose Rackow, ... Robert Matthew Kottmann in Respiratory Research
    Article Open access 24 December 2022
  13. Impact of Myocardial Fibrosis on Cardiovascular Structure, Function and Functional Status in Heart Failure with Preserved Ejection Fraction

    Myocardial fibrosis, measured using cardiovascular magnetic resonance extracellular volume (ECV), is associated with adverse outcome in heart failure...

    Gavin A. Lewis, Anna Rosala-Hallas, ... Christopher A. Miller in Journal of Cardiovascular Translational Research
    Article Open access 05 July 2022
  14. Body fluid-derived stem cells — an untapped stem cell source in genitourinary regeneration

    Somatic stem cells have been obtained from solid organs and tissues, including the bone marrow, placenta, corneal stroma, periosteum, adipose tissue,...

    Ru-Lin Huang, Qingfeng Li, ... Yuanyuan Zhang in Nature Reviews Urology
    Article 06 July 2023
  15. Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis

    Idiopathic pulmonary fibrosis (IPF) remains a disease with poor survival. The pathogenesis is complex and encompasses multiple molecular pathways....

    Francesco Bonella, Paolo Spagnolo, Chris Ryerson in Drugs
    Article Open access 26 October 2023
  16. Ovarian fibrosis: molecular mechanisms and potential therapeutic targets

    Ovarian fibrosis, characterized by the excessive proliferation of ovarian fibroblasts and the accumulation of extracellular matrix (ECM), serves as...

    Mengqing Gu, Yibo Wang, Yang Yu in Journal of Ovarian Research
    Article Open access 05 July 2024
  17. Current Therapeutic Approaches in Scleroderma: Clinical Models of Effective Antifibrotic Therapies

    Purpose of review

    Systemic sclerosis (SSc) is a disease characterized by fibrosis of the skin and internal organs. In this article, we review some of...

    Sindhu R. Johnson, Daniel E. Furst in Current Treatment Options in Rheumatology
    Article 08 November 2020
  18. Targeting integrin pathways: mechanisms and advances in therapy

    Integrins are considered the main cell-adhesion transmembrane receptors that play multifaceted roles as extracellular matrix (ECM)-cytoskeletal...

    **aocong Pang, Xu He, ... Yimin Cui in Signal Transduction and Targeted Therapy
    Article Open access 02 January 2023
  19. Kidney fibrosis: from mechanisms to therapeutic medicines

    Chronic kidney disease (CKD) is estimated to affect 10–14% of global population. Kidney fibrosis, characterized by excessive extracellular matrix...

    Rongshuang Huang, ** Fu, Liang Ma in Signal Transduction and Targeted Therapy
    Article Open access 17 March 2023
  20. Effect of extracorporeal shockwave therapy for rotator cuff tendinopathy: a systematic review and meta-analysis

    Background

    Rotator cuff tendinopathy (RCT) is a widespread musculoskeletal disorder and a primary cause of shoulder pain and limited function. The...

    **ali Xue, Qingfa Song, ... Guoqing Cui in BMC Musculoskeletal Disorders
    Article Open access 04 May 2024
Did you find what you were looking for? Share feedback.